Angelina Jolie made headlines recently for undergoing a double mastectomy because she carried the gene highly associated with hereditary breast cancer. The biotech firm, Myriad Genetics, that isolated the gene tried to patent it. In a unanimous decision, the Supreme Court ruled that “a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” However, synthetically created strands of DNA are eligible because they do not occur in nature.

Read the story.